Advertising and Marketing
January 12, 2023
[ad_1] Or are they just glorified candy bars? [ad_2] Source link
December 29, 2022
[ad_1] The report said the FDA’s approval process for Aduhelm was “riddled with irregularities” and criticized Biogen for setting an “unjustifiably high price.” [ad_2] Source link
December 10, 2022
[ad_1] The proposed deal would settle thousands of claims in multidistrict litigation based in Northern California. [ad_2] Source link
